Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma (NCT05412290)

🔬

Loading study...

Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma (NCT05412290) | TrialReferrals